Abstract
We investigated a potential molecular target for anti-colitic effects of esculetin, 6,7-dihydroxycoumarin. Esculetin administered rectally effectively ameliorated TNBS-induced rat colitis and attenuated the expression of pro-inflammatory mediators in the inflamed colon. In human colon carcinoma HCT116 cells, esculetin induced hypoxia-inducible factor-1α (HIF-1α), leading to secretion of vascular endothelial growth factor, a HIF-1 target gene product involved in ulcer healing of the gastrointestinal mucosa. Esculetin directly inhibited HIF prolyl hydroxylase-2 (HPH-2), an enzyme playing a major role in negatively regulating HIF-1α protein stability. Esculetin inhibition of HPH and consequent induction of HIF-1α were attenuated by escalating dose of either ascorbate or 2-ketoglutarate, the required factors of the enzyme. Structurally, the catechol moiety in esculetin was required for HPH inhibition. Collectively, HPH may be a molecular target for esculetin-mediated anti-colitic effects and the catechol moiety in esculetin is the pharmacophore for HPH inhibition.
References
Apr 19, 1977·Biochemistry·R A BergD J Prockop
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Oct 31, 1998·Current Opinion in Genetics & Development·G L Semenza
Apr 9, 2001·Science·P JaakkolaP J Ratcliffe
Apr 9, 2001·Science·M IvanW G Kaelin
Oct 13, 2001·Science·R K Bruick, S L McKnight
Jun 8, 2002·The Journal of Biological Chemistry·Jennifer S IsaacsLeonard M Neckers
Jun 6, 2003·The Journal of Biological Chemistry·Maija HirsiläJohanna Myllyharju
Oct 19, 2004·The Journal of Clinical Investigation·Jörn KarhausenVolker H Haase
Dec 8, 2004·Current Pharmaceutical Design·Aoife Lacy, Richard O'Kennedy
Dec 8, 2004·Current Pharmaceutical Design·Konstantina C FylaktakidouDemetrios N Nicolaides
Apr 20, 2005·Journal of Cardiovascular Pharmacology·Hiroshi HashimotoKatsuko Yamashito
Mar 23, 2007·Molecular Pharmacology·Hyunchu JeonYunjin Jung
Jan 2, 2008·Gastroenterology·Andreas RobinsonSean P Colgan
Jan 2, 2008·Gastroenterology·Eoin P CumminsCormac T Taylor
Jan 20, 2009·Recent Patents on Inflammation & Allergy Drug Discovery·Simon A HirotaJustin A MacDonald
Sep 11, 2009·The Journal of Nutritional Biochemistry·Daekyu ChoiYunjin Jung
Apr 13, 2010·Chemico-biological Interactions·Aline WitaicenisLuiz C Di Stasi
Jul 6, 2010·Gastroenterology·Murtaza M TambuwalaCormac T Taylor
Feb 4, 2012·Current Medicinal Chemistry·A S Tarnawski, A Ahluwalia
Mar 21, 2012·Molecular Pharmaceutics·Sungchae HongYunjin Jung
Sep 25, 2012·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ying-yi LiNing-sheng Wang
Dec 25, 2012·European Journal of Pharmacology·Soohwan YumYunjin Jung
Nov 2, 2013·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Aline WitaicenisLuiz Claudio Di Stasi
Jan 28, 2014·European Journal of Pharmacology·Yonghyun LeeYunjin Jung
Citations
Jun 24, 2017·Eye·D JiangJ Hu
Feb 13, 2018·Molecular and Cellular Biochemistry·Renganathan SelvasundaramRadhakrishnan Murali Naidu
Jan 21, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luiz C Di Stasi
Oct 19, 2021·Cell Biology International·Jiuheng YinHua Yang
Nov 23, 2021·Phytotherapy Research : PTR·Linlin ZhangXiaofang Li